Acadia Healthcare (ACHC) Price Target Raised to $31 After Q1 Beat

Acadia Healthcare Company, Inc. (ACHC) received an upgraded price target from RBC Capital, increasing from $28 to $31 following its fiscal Q1 earnings beat. The firm maintained an Outperform rating on the stock. Similarly, Raymond James upgraded ACHC to Strong Buy, raising its price target from $25 to $39. The analysts noted an increased EBITDA and earnings outlook for 2026 and highlighted the company's strategy to achieve a $200 million target from underperforming facilities. This positive sentiment could potentially lead to an upward movement in ACHC's stock price in the near term.